Middle East and Africa Neonatal Jaundice Management Market, By Management (Diagnosis, Treatment), Type (Primary Care, Secondary Care), Technology (Light-Emitting Diode Light Sources, Fluorescent, Halogen, Fiberoptic, Others), End User (Hospitals, Clinics, Ambulatory Surgical Centers, Home Users, Others), Distribution Channel (Direct Tender, Retail Sales, Third Party Distribution), Country (Saudi Arabia, South Africa, UAE, Israel, Egypt and Rest of Middle East and Africa) Industry Trends and Forecast to 2028
Market Analysis and Insights: Middle East and Africa Neonatal Jaundice Management Market
The neonatal jaundice management market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 5.3% in the forecast period of 2021 to 2028 and is expected to reach USD 18.61 million by 2028. The rising number of neonatal jaundice patients and technological advancement for disease testing and treatment are the major drivers which propelled the demand of the neonatal jaundice management market in the forecast period.
The term jaundice is derived from the French word ‘jaune’ which means yellow. Neonatal jaundice is characterized by the appearance of yellowish color in skin as well as eyes (sclera and conjunctiva). It is one of the most common diseases in newborns that occur in the first week of after birth. It occurs mainly in 60% of term and 80% of preterm infant.
The increase in number of preterm births especially in Middle East and African region require extra treatment for jaundice and these babies have to stay in the hospital under the care of physician and should be monitored daily which may increase the neonatal jaundice management market growth. The less adoption of the neonatal jaundice management treatment and diagnosis especially in low-income countries may act as a restraint for the neonatal jaundice management market growth. The increasing healthcare expenditure can lead to advancement in technologies and increase in the treatment options which may act as an opportunity for the growth of the neonatal jaundice management market. The complications related with the neonatal jaundice are the challenging factor for the patient population as well as the researchers and physicians in the neonatal jaundice management market.
The neonatal jaundice management market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the neonatal jaundice management market scenario contact Data Bridge Market Research for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.
Middle East and Africa Neonatal Jaundice Management Market Scope and Market Size
The neonatal jaundice management market is segmented on the basis of the management, type, technology, end user and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of management, the neonatal jaundice management market is segmented into treatment and diagnosis. In 2021, diagnosis segment is expected to dominate the neonatal jaundice management market because of rising prevalence of neonatal jaundice and neonatal jaundice diagnosis which is mandatory for every child.
- On the basis of type, the neonatal jaundice management market is segmented into primary care and secondary care. In 2021, primary care segment is expected to dominate the neonatal jaundice management market because primary care is the common and initial criteria for the neonatal infant care suffering from jaundice.
- On the basis of technology, the neonatal jaundice management market is segmented into fluorescent, halogen, fiberoptic, light-emitting diode light sources and others. In 2021, light-emitting diode light sources segment is expected to dominate the neonatal jaundice management market as most of the healthcare facilities have LED based products and these products are highly effective.
- On the basis of end user, the neonatal jaundice management market is segmented into hospitals, clinics, ambulatory surgical centers, home users and others. In 2021, hospitals segment is dominating the neonatal jaundice management market because of presence of highly specialized professional and presence of well-equipped technology for the treatment of neonatal jaundice.
- On the basis of distribution channel, the neonatal jaundice management market is segmented into direct tender, retail sales and third party distribution. In 2021, direct tender segment is expected to dominate the neonatal jaundice management market because phototherapy devices or equipment are costly which required multiple vendor analysis for the purchase of device.
Neonatal Jaundice Management Market Country Level Analysis
The neonatal jaundice management market is analyzed and market size information is provided by the country, management, type, technology, end user and distribution channel as referenced above.
The countries covered in the Middle East and Africa neonatal jaundice management market report are the Saudi Arabia, South Africa, UAE, Israel, Egypt and Rest of Middle East and Africa.
Diagnosis segment in Middle East and Africa region is expected to grow with the highest growth rate in the forecast period of 2021 to 2028 because of rising prevalence of neonatal jaundice. South Africa is leading the growth of the Middle East and Africa market and diagnosis segment is dominating in this region due to government initiatives to create awareness among the pregnant females.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Technological Advancement and Effective Phototherapy Treatment are boosting the Neonatal Jaundice Management Market Growth
The neonatal jaundice management market also provides you with detailed market analysis for every country growth in neonatal jaundice management industry with neonatal jaundice management drugs sales, impact of advancement in the neonatal jaundice management technology and changes in regulatory scenarios with their support for the neonatal jaundice management market. The data is available for historic period 2010 to 2019.
Competitive Landscape and Neonatal jaundice management Market Share Analysis
The neonatal jaundice management market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to neonatal jaundice management market.
The major companies which are dealing in the neonatal jaundice management are Atom Medical Corp., avihealthcare, Ibis Medical, Natus Medical Incorporated., DAVID, Signify Holding., Weyer GmbH, nice Neotech Medical Systems Pvt. Ltd., Phoenix Medical Systems (P) Ltd, Aeroflow, Inc., Zhengzhou Dison Instrument And Meter Co., Ltd, GENERAL ELECTRIC COMPANY, Neolight, Ardo, NeoMedLight, S S TECHNOMED(P)LTD, Drägerwerk AG & Co. KGaA, Braun & Co. Limited, HERBERT WALDMANN GMBH & CO. KG, GINEVRI srl, Shvabe Zurich GmbH among others.
Many product launch and agreement are also initiated by the companies’ worldwide which are also accelerating the neonatal jaundice management market.
For instance,
- In July 2019, Atom Medical Corp. had announced that the company had absorbed and merged the subsidiary, ATOM Medical International, Inc. (AMI). The AMI will be now the division of Atom Medical Corp and the business will continued by this company. This helped the company to increase their market share and expand their business globally.
- In January 2020, nice Nanotech Medical Systems Pvt. Ltd. had announced for the expansion of their neonatal product range due to positive result from both domestic and international markets. The company had thought about the collaboration so as to expand the promotion of the products. This expansion helped the company to explore the market and expand their business in order to increase the market sale of the product globally.
Collaboration, product launch, business expansion, award and recognition, joint ventures and other strategies by the market players is enhancing the company market in the neonatal jaundice management market which also provides the benefit for organization to improve their offering for neonatal jaundice management.
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 MANAGEMENT LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 MARKET MANAGEMENT COVERAGE GRID
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: LAWS AND REGULATIONS
5 MARKET OVERVIEW
5.1 DRIVERS
5.1.1 RISING PATIENT POPULATION SUFFERING FROM NEONATAL JAUNDICE
5.1.2 LARGE NUMBER OF RISK FACTORS
5.1.3 RISING NUMBER OF NEW-BORN INFANTS
5.1.4 INCREASE IN PRETERM BIRTH
5.1.5 AWARENESS ABOUT NEONATAL JAUNDICE AMONG THE POPULATION
5.2 RESTRAINTS
5.2.1 SIDE-EFFECTS RELATED TO PHOTOTHERAPY
5.2.2 PRODUCT RECALLS
5.2.3 LIMITED ADOPTION OF NEONATAL JAUNDICE MANAGEMENT
5.3 OPPORTUNITIES
5.3.1 INCREASING HEALTHCARE EXPENDITURE
5.3.2 TECHNOLOGICAL ADVANCEMENT IN DIAGNOSIS AND TREATMENT
5.3.3 INCREASING DISPOSABLE INCOME
5.3.4 INCREASE IN AGREEMENTS AND ACQUISITIONS
5.4 CHALLENGES
5.4.1 COMPLICATIONS RELATED TO NEONATAL JAUNDICE
5.4.2 LACK OF SKILLED PROFESSIONALS
5.4.3 DIAGNOSIS OF NEONATAL JAUNDICE
6 COVID-19 IMPACT ON MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET IN HEALTHCARE INDUSTRY
6.1 PRICE IMPACT
6.2 IMPACT ON DEMAND
6.3 IMPACT ON SUPPLY CHAIN
6.4 STRATEGIC DECISION FOR MANUFACTURERS / SERVICE PROVIDERS
6.5 CONCLUSION
7 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT
7.1 OVERVIEW
7.2 DIAGNOSIS
7.2.1 TRANSCUTANEOUS BILIRUBINOMETER (TCB)
7.2.2 TOTAL SERUM BILIRUBIN (TSB)
7.2.3 VISUAL ASSESSMENT
7.3 TREATMENT
7.3.1 PHOTOTHERAPY
7.3.1.1 LED PHOTOTHERAPY
7.3.1.2 FIBREOPTIC PHOTOTHERAPY
7.3.1.3 CONVENTIONAL PHOTOTHERAPY
7.3.1.3.1 CONVENTIONAL PHOTOTHERAPY WITH COMPACT FLUORESCENT LAMP
7.3.1.3.2 CONVENTIONAL PHOTOTHERAPY WITH FLUORESCENT LAMP
7.3.1.3.2.1 FULL-BODY PHOTOTHERAPY
7.3.1.3.2.2 PARTIAL-BODY PHOTOTHERAPY
7.3.2 EXCHANGE TRANSFUSION
7.3.3 INTRAVENOUS IMMUNOGLOBULIN
7.3.4 OTHERS
8 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET, BY TYPE
8.1 OVERVIEW
8.2 PRIMARY CARE
8.3 SECONDARY CARE
9 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET, BY TECHNOLOGY
9.1 OVERVIEW
9.2 LIGHT-EMITTING DIODE LIGHT SOURCES
9.3 FIBEROPTIC
9.4 FLUORESCENT
9.5 HALOGEN
10 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET, BY END USER
10.1 OVERVIEW
10.2 HOSPITALS
10.3 CLINICS
10.4 HOME USERS
10.5 AMBULATORY SURGICAL CENTERS
10.6 OTHERS
11 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL
11.1 OVERVIEW
11.2 DIRECT TENDERS
11.3 RETAIL SALES
11.4 THIRD PARTY DISTRIBUTION
12 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET BY GEOGRAPHY
12.1 MIDDLE EAST AND AFRICA
12.1.1 SOUTH AFRICA
12.1.2 SAUDI ARABIA
12.1.3 UAE
12.1.4 ISRAEL
12.1.5 EGYPT
12.1.6 REST OF MIDDLE EAST AND AFRICA
13 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: COMPANY LANDSCAPE
13.1 COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA
14 SWOT
15 COMPANY PROFILES
15.1 SIGNIFY HOLDING
15.1.1 COMPANY SNAPSHOT
15.1.2 REVENUE FINANCIALS
15.1.3 COMPANY SHARE ANALYSIS
15.1.4 PRODUCT PORTFOLIO
15.1.5 RECENT DEVELOPMENTS
15.2 GE HEALTHCARE (A SUBSIDIARY OF GENERAL ELECTRIC COMPANY)
15.2.1 COMPANY SNAPSHOT
15.2.2 RECENT FINANCIALS
15.2.3 COMPANY SHARE ANALYSIS
15.2.4 PRODUCT PORTFOLIO
15.2.5 RECENT DEVELOPMENTS
15.3 ATOM MEDICAL CORP.
15.3.1 COMPANY SNAPSHOT
15.3.2 COMPANY SHARE ANALYSIS
15.3.3 PRODUCT PORTFOLIO
15.3.4 RECENT DEVELOPMENTS
15.4 NATUS MEDICAL INCORPORATED
15.4.1 COMPANY SNAPSHOT
15.4.2 RECENT FINANCIALS
15.4.3 COMPANY SHARE ANALYSIS
15.4.4 PRODUCT PORTFOLIO
15.4.5 RECENT DEVELOPMENTS
15.5 DRAGERWERK AG & CO. KGAA
15.5.1 COMPANY SNAPSHOT
15.5.2 RECENT FINANCIALS
15.5.3 PRODUCT PORTFOLIO
15.5.4 RECENT DEVELOPMENT
15.6 HERBERT WALDMANN GMBH & CO. KG
15.6.1 COMPANY SNAPSHOT
15.6.2 PRODUCT PORTFOLIO
15.6.3 RECENT DEVELOPMENTS
15.7 AEROFLOW, INC.
15.7.1 COMPANY SNAPSHOT
15.7.2 PRODUCT PORTFOLIO
15.7.3 RECENT DEVELOPMENT
15.8 ARDO
15.8.1 COMPANY SNAPSHOT
15.8.2 PRODUCT PORTFOLIO
15.8.3 RECENT DEVELOPMENT
15.9 AVIHEALTHCARE
15.9.1 COMPANY SNAPSHOT
15.9.2 PRODUCT PORTFOLIO
15.9.3 RECENT DEVELOPMENTS
15.1 BRAUN & CO. LIMITED
15.10.1 COMPANY SNAPSHOT
15.10.2 PRODUCT PORTFOLIO
15.10.3 RECENT DEVELOPMENTS
15.11 DAVID
15.11.1 COMPANY SNAPSHOT
15.11.2 PRODUCT PORTFOLIO
15.11.3 RECENT DEVELOPMENTS
15.12 GINEVRI SRL
15.12.1 COMPANY SNAPSHOT
15.12.2 PRODUCT PORTFOLIO
15.12.3 RECENT DEVELOPMENTS
15.13 IBIS MEDICAL
15.13.1 COMPANY SNAPSHOT
15.13.2 PRODUCT PORTFOLIO
15.13.3 RECENT DEVELOPMENTS
15.14 NEOLIGHT
15.14.1 COMPANY SNAPSHOT
15.14.2 PRODUCT PORTFOLIO
15.14.3 RECENT DEVELOPMENTS
15.15 NEOMEDLIGHT
15.15.1 COMPANY SNAPSHOT
15.15.2 PRODUCT PORTFOLIO
15.15.3 RECENT DEVELOPMENTS
15.16 NICE NANOTECH MEDICAL SYSTEMSPVT. LTD.
15.16.1 COMPANY SNAPSHOT
15.16.2 PRODUCT PORTFOLIO
15.16.3 RECENT DEVELOPMENTS
15.17 PHOENIX MEDICAL SYSTEMS (P) LTD
15.17.1 COMPANY SNAPSHOT
15.17.2 PRODUCT PORTFOLIO
15.17.3 RECENT DEVELOPMENTS
15.18 S S TECHNOMED (P) LTD
15.18.1 COMPANY SNAPSHOT
15.18.2 PRODUCT PORTFOLIO
15.18.3 RECENT DEVELOPMENT
15.19 SHVABE ZURICH GMBH
15.19.1 COMPANY SNAPSHOT
15.19.2 PRODUCT PORTFOLIO
15.19.3 RECENT DEVELOPMENTS
15.2 WEYER GMBH
15.20.1 COMPANY SNAPSHOT
15.20.2 PRODUCT PORTFOLIO
15.20.3 RECENT DEVELOPMENT
15.21 ZHENGZHOU DISON INSTRUMENT AND METER CO., LTD
15.21.1 COMPANY SNAPSHOT
15.21.2 PRODUCT PORTFOLIO
15.21.3 RECENT DEVELOPMENT
16 QUESTIONNAIRE
17 RELATED REPORTS
List of Table
LIST OF TABLES
TABLE 1 REGULATION IMPOSED BY SEVERAL REGULATORY AGENCIES IN DIFFERENT REGIONS
TABLE 2 RISK FACTORS FOR NEONATAL JAUNDICE
TABLE 3 CHARACTERISTICS OF TERM AND PRETERM INFANTS
TABLE 4 HEALTHCARE EXPENDITURE IN ASIA
TABLE 5 QUESTIONNAIRE FOR THE ONLINE FOLLOW-UP
TABLE 6 TIME SCHEDULE OF ONLINE FOLLOW-UP AFTER DISCHARGE
TABLE 7 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)
TABLE 8 MIDDLE EAST AND AFRICA DIAGNOSIS IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 9 MIDDLE EAST AND AFRICA DIAGNOSIS IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)
TABLE 10 MIDDLE EAST AND AFRICA TREATMENT IN NEONATAL JAUNDICE MANAGEMENTMARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 11 MIDDLE EAST AND AFRICA TREATMENT IN NEONATAL JAUNDICE MANAGEMENTMARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)
TABLE 12 MIDDLE EAST AND AFRICA TREATMENT BY PHOTOTHERAPY IN NEONATAL JAUNDICE MANAGEMENTMARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)
TABLE 13 MIDDLE EAST AND AFRICA TREATMENT BY CONVENTIONAL PHOTOTHERAPY IN NEONATAL JAUNDICE MANAGEMENTMARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)
TABLE 14 MIDDLE EAST AND AFRICA TREATMENT BY CONVENTIONAL PHOTOTHERAPY WITH FLUORESCENT LAMP IN NEONATAL JAUNDICE MANAGEMENTMARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)
TABLE 15 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 16 MIDDLE EAST AND AFRICA PRIMARY CARE IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 17 MIDDLE EAST AND AFRICA SECONDARY CARE IN NEONATAL JAUNDICE MANAGEMENTMARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 18 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 19 MIDDLE EAST AND AFRICA LIGHT-EMITTING DIODE LIGHT SOURCES IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 20 MIDDLE EAST AND AFRICA FIBEROPTIC IN NEONATAL JAUNDICE MANAGEMENTMARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 21 MIDDLE EAST AND AFRICA FLUORESCENT IN NEONATAL JAUNDICE MANAGEMENTMARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 22 MIDDLE EAST AND AFRICA HALOGEN IN NEONATAL JAUNDICE MANAGEMENTMARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 23 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 24 MIDDLE EAST AND AFRICA HOSPITALS IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 25 MIDDLE EAST AND AFRICA CLINICS IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 26 MIDDLE EAST AND AFRICA HOME USERS IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 27 MIDDLE EAST AND AFRICA AMBULATORY SURGICAL CENTERS IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 28 MIDDLE EAST AND AFRICA OTHERS IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 29 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 30 MIDDLE EAST AND AFRICA DIRECT TENDERS IN NEONATAL JAUNDICE MANAGEMENT MARKET, REGION, 2019-2028 (USD MILLION)
TABLE 31 MIDDLE EAST AND AFRICA RETAIL SALES IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 32 MIDDLE EAST AND AFRICA THIRD PARTY DISTRIBUTION IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 33 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET, BY COUNTRY, 2018-2028 (USD MILLION)
TABLE 34 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)
TABLE 35 MIDDLE EAST AND AFRICA DIAGNOSIS IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)
TABLE 36 MIDDLE EAST AND AFRICA TREATMENT IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)
TABLE 37 MIDDLE EAST AND AFRICA TREATMENT IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)
TABLE 38 MIDDLE EAST AND AFRICA TREATMENT BY CONVENTIONAL PHOTOTHERAPY IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)
TABLE 39 MIDDLE EAST AND AFRICA TREATMENT BY CONVENTIONAL PHOTOTHERAPY WITH FLUORESCENT LAMPIN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)
TABLE 40 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 41 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 42 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 43 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 44 SOUTH AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)
TABLE 45 SOUTH AFRICA DIAGNOSIS IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)
TABLE 46 SOUTH AFRICA TREATMENT IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)
TABLE 47 SOUTH AFRICA TREATMENT IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)
TABLE 48 SOUTH AFRICA TREATMENT BY CONVENTIONAL PHOTOTHERAPY IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)
TABLE 49 SOUTH AFRICA TREATMENT BY CONVENTIONAL PHOTOTHERAPY WITH FLUORESCENT LAMPIN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)
TABLE 50 SOUTH AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 51 SOUTH AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 52 SOUTH AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 53 SOUTH AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 54 SAUDI ARABIA NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)
TABLE 55 SAUDI ARABIA DIAGNOSIS IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)
TABLE 56 SAUDI ARABIA TREATMENT IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)
TABLE 57 SAUDI ARABIA TREATMENT IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)
TABLE 58 SAUDI ARABIA TREATMENT BY CONVENTIONAL PHOTOTHERAPY IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)
TABLE 59 SAUDI ARABIA TREATMENT BY CONVENTIONAL PHOTOTHERAPY WITH FLUORESCENT LAMPIN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)
TABLE 60 SAUDI ARABIA NEONATAL JAUNDICE MANAGEMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 61 SAUDI ARABIA NEONATAL JAUNDICE MANAGEMENT MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 62 SAUDI ARABIA NEONATAL JAUNDICE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 63 SAUDI ARABIA NEONATAL JAUNDICE MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 64 UAE NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)
TABLE 65 UAE DIAGNOSIS IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)
TABLE 66 UAE TREATMENT IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)
TABLE 67 UAE TREATMENT IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)
TABLE 68 UAE TREATMENT BY CONVENTIONAL PHOTOTHERAPY IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)
TABLE 69 UAE TREATMENT BY CONVENTIONAL PHOTOTHERAPY WITH FLUORESCENT LAMPIN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)
TABLE 70 UAE NEONATAL JAUNDICE MANAGEMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 71 UAE NEONATAL JAUNDICE MANAGEMENT MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 72 UAE NEONATAL JAUNDICE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 73 UAE NEONATAL JAUNDICE MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 74 ISRAEL NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)
TABLE 75 ISRAEL DIAGNOSIS IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)
TABLE 76 ISRAEL TREATMENT IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)
TABLE 77 ISRAEL TREATMENT IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)
TABLE 78 ISRAEL TREATMENT BY CONVENTIONAL PHOTOTHERAPY IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)
TABLE 79 ISRAEL TREATMENT BY CONVENTIONAL PHOTOTHERAPY WITH FLUORESCENT LAMPIN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)
TABLE 80 ISRAEL NEONATAL JAUNDICE MANAGEMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 81 ISRAEL NEONATAL JAUNDICE MANAGEMENT MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 82 ISRAEL NEONATAL JAUNDICE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 83 ISRAEL NEONATAL JAUNDICE MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 84 EGYPT NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)
TABLE 85 EGYPT DIAGNOSIS IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)
TABLE 86 EGYPT TREATMENT IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)
TABLE 87 EGYPT TREATMENT IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)
TABLE 88 EGYPT TREATMENT BY CONVENTIONAL PHOTOTHERAPY IN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)
TABLE 89 EGYPT TREATMENT BY CONVENTIONAL PHOTOTHERAPY WITH FLUORESCENT LAMPIN NEONATAL JAUNDICE MANAGEMENT MARKET, BY MANAGEMENT, 2019-2028 (USD MILLION)
TABLE 90 EGYPT NEONATAL JAUNDICE MANAGEMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 91 EGYPT NEONATAL JAUNDICE MANAGEMENT MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 92 EGYPT NEONATAL JAUNDICE MANAGEMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 93 EGYPT NEONATAL JAUNDICE MANAGEMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 94 REST OF MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
List of Figure
LIST OF FIGURES
FIGURE 1 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: SEGMENTATION
FIGURE 2 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: DATA TRIANGULATION
FIGURE 3 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: DROC ANALYSIS
FIGURE 4 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: MIDDLE EAST AND AFRICA VS. REGIONAL MARKET ANALYSIS
FIGURE 5 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: MULTIVARIATE MODELLING
FIGURE 7 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 8 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: DBMR MARKET POSITION GRID
FIGURE 9 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: MARKET MANAGEMENT COVERAGE GRID
FIGURE 11 MIDDLE EAST AND AFRICA BRONCHIECTASIS MARKET: SEGMENTATION
FIGURE 12 RISING PATIENT POPULATION SUFFERING FROM NEONATAL JAUNDICE IS DRIVING THE MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 13 MANAGEMENT SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET IN 2021 & 2028
FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET
FIGURE 15 GRAPHICAL REPRESENTATION FOR NUMBER OF CHILDBIRTH ON THE BASIS OF DIFFERENT REGIONS
FIGURE 16 GRAPHICAL REPRESENTATION FOR NUMBER OF PRETERM CHILDBIRTH FOR DIFFERENT COUNTRIES
FIGURE 17 HEALTH SPENDING BY MAJOR NUMBER OF FUNDS
FIGURE 18 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: BY MANAGEMENT, 2021
FIGURE 19 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: BY MANAGEMENT, 2019-2028 (USD MILLION)
FIGURE 20 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: BY MANAGEMENT, CAGR (2021-2028)
FIGURE 21 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: BY MANAGEMENT, LIFELINE CURVE
FIGURE 22 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: BY TYPE, 2021
FIGURE 23 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: BY TYPE, 2019-2028 (USD MILLION)
FIGURE 24 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: BY TYPE, CAGR (2021-2028)
FIGURE 25 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: BY TYPE, LIFELINE CURVE
FIGURE 26 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: BY TECHNOLOGY, 2021
FIGURE 27 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: BY TECHNOLOGY, 2019-2028 (USD MILLION)
FIGURE 28 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: BY TECHNOLOGY, CAGR (2021-2028)
FIGURE 29 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: BY TECHNOLOGY, LIFELINE CURVE
FIGURE 30 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: BY END USER, 2021
FIGURE 31 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: BY END USER, 2019-2028 (USD MILLION)
FIGURE 32 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: BY END USER, CAGR (2021-2028)
FIGURE 33 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: BY END USER, LIFELINE CURVE
FIGURE 34 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: BY DISTRIBUTION CHANNEL, 2021
FIGURE 35 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
FIGURE 36 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: BY DISTRIBUTION CHANNEL, CAGR (2021-2028)
FIGURE 37 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 38 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: SNAPSHOT (2020)
FIGURE 39 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: BY COUNTRY (2020)
FIGURE 40 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: BY COUNTRY (2021 & 2028)
FIGURE 41 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: BY COUNTRY (2020 & 2028)
FIGURE 42 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: BY MANAGEMENT (2021-2028)
FIGURE 43 MIDDLE EAST AND AFRICA NEONATAL JAUNDICE MANAGEMENT MARKET: COMPANY SHARE 2020 (%)
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
